F13.221 Sedative, hypnotic or anxiolytic dependence with intoxication delirium

Name of the Condition

• Sedative, Hypnotic, or Anxiolytic Dependence with Intoxication Delirium (ICD-10 Code: F13.221)

Summary

This condition involves dependence on sedative, hypnotic, or anxiolytic substances, accompanied by intoxication delirium. It is characterized by a physical or psychological reliance on these drugs, often prescribed for anxiety or sleep disorders, leading to impaired functioning when the substance is used or when withdrawal occurs. Delirium may present with acute confusion, disorientation, or fluctuating mental status.

Causes

The condition typically develops from prolonged use or misuse of sedative, hypnotic, or anxiolytic medications. It may begin with therapeutic use and progress to dependence due to factors like increased tolerance, continued use despite negative consequences, or self-medication for underlying mental health issues. Delirium can arise from acute intoxication or withdrawal.

Risk Factors

• Contributing factors include a history of substance abuse, co-occurring mental health disorders, chronic stress, and environments where these substances are easily accessible. Genetic predispositions and prior exposure to similar drugs may also increase risk. Older age, polypharmacy, and pre-existing cognitive impairment can heighten delirium risk.

Symptoms

• Symptoms include a strong desire to use the substance, difficulty controlling use, increased tolerance, withdrawal symptoms when not using, and continued use despite physical or psychological harm. Intoxication delirium may present with acute confusion, disorientation, fluctuating alertness, hallucinations, or agitation.

Diagnosis

Diagnosis is based on a clinical evaluation, including patient history, symptom assessment, and standardized criteria for substance dependence and delirium. Laboratory tests may be used to rule out other causes of delirium, such as metabolic or infectious etiologies. A thorough review of substance use patterns and mental status is essential.

Treatment Options

Treatment focuses on managing delirium, addressing withdrawal, and supporting recovery. Interventions may include benzodiazepine tapering, supportive care, and monitoring for complications. Long-term treatment often involves behavioral therapies, counseling, and support groups to address dependence.

Prognosis and Follow-Up

Prognosis depends on the severity of dependence, delirium, and underlying health. Early intervention improves outcomes, but delirium can increase mortality risk. Follow-up care should include regular monitoring for relapse, mental health support, and coordination with addiction specialists.

Complications

Complications may include severe withdrawal, seizures, respiratory depression, or prolonged cognitive impairment. Delirium can lead to falls, injuries, or other medical issues. Chronic dependence may result in social, occupational, or legal problems.

Lifestyle & Prevention

Lifestyle modifications include avoiding substance misuse, adhering to prescribed dosages, and seeking help for mental health concerns. Prevention strategies involve education on risks, safe storage of medications, and avoiding mixing substances with alcohol or other drugs.

When to Seek Professional Help

Seek immediate care if delirium symptoms (e.g., confusion, hallucinations) or severe withdrawal (e.g., seizures, agitation) occur. Ongoing support from healthcare providers is recommended for managing dependence and preventing relapse.

Tips for Medical Coders

Document the presence of intoxication delirium and its relationship to sedative, hypnotic, or anxiolytic dependence. Ensure clinical notes specify the substance type, delirium onset, and any contributing factors. Code F13.221 requires clear evidence of both dependence and delirium to support accurate reporting.